JohnGregoryDuffyMD

Psychiatry • Santa Ana, CA

President, Syrentis Clinical Research, Dementia Specialist

Join to view full profile

Dr. Duffy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Duffy's full profile

Already have an account?

Office
1401 N Tustin Ave
Ste 130
Santa Ana, CA 92705
Phone+1 714-542-3008

Fax+1 714-542-3617

Summary

Dr. John Gregory Duffy is a geriatric psychiatrist in Santa Ana, CA. He received his medical degree from Georgetown University School of Medicine. He is experienced in the diagnosis and treatment of all forms of dementia and specializes in geriatric psychiatry. Dr. Duffy is the owner and principal investigator of Syrentis Clinical Research, a multispecialty clinical trials site, where he focuses his time on the development of new treatments for Alzheimer’s and other forms of dementia.

Education & Training

University of California (Irvine)Residency, Psychiatry, 1994 - 1998
Georgetown University School of MedicineClass of 1994
UCLA School of Public HealthMSPH, Health Policy and Planning
UCLABS, Psychobiology

Certifications & Licensure

CA State Medical License 1995 - 2025

Clinical Trials

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Memory Improvement Through Nicotine Dosing (MIND) Study Start of enrollment: 2017 Jan 13
Active, not recruiting
Phase 2
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Terminated
Phase 3
A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease Start of enrollment: 2017 May 09
Completed
Phase 1, Phase 2
Tau Screening Study in Patients With Early Symptomatic AD Start of enrollment: 2017 Nov 21
Completed
Phase 2
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease Start of enrollment: 2019 Mar 28
Completed
Phase 2, Phase 3
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents Start of enrollment: 2019 Jun 28
Completed
Phase 2
Join now to see all

Press Mentions

EXCLUSIVE: Dr. John Duffy Gives Parents Insight into Helping Kids with AnxietyJanuary 15th, 2020